You may draw cards until you have 6 cards in your hand.
Discard all Energy from this Pokémon.
Release year for Ascended Heroes is 2026. It belongs to the Mega Evolution series.
With 295 listed cards, this is a very large set by modern TCG standards. As of this year, it is one of the newest tracked releases.
Cynthia's Garchomp ex (#111) is one of the DoubleRare prints in this expansion.
Cynthia's Garchomp ex appears in Ascended Heroes, released in 2026. Core profile: Its card type is Pokémon., The rarity label is DoubleRare., Printed HP is 330., and Energy typing is Fighting.
Card subtype classification is Stage 2, ex, and Trainer-Owned. The printed attacks highlight "Corkscrew Dive" and "Draconic Buster".
Grass weakness applies to this print. Retreat cost is free (0 energy required).
Within set composition, this rarity normally lands above common and uncommon print tiers.
Cynthia's Garchomp ex (Ascended Heroes) is presently valued at about $0.97 in raw condition. Its 7-day trend is positive, up 10.2%.
Current pricing is broadly aligned with its 30-day average ($0.95). Its 90-day trading band runs between $0.88 and $1.04, producing a 16% range and low-volatility behavior.
The listed rarity for this print is DoubleRare.
Cynthia's Garchomp ex sits within a broader pool of Cynthia's variants that can be compared by set, rarity, and price. This comparison sample includes 4 alternatives across 1 set.
In this sample, pricing ranges between $0.97 and $194.11 (19911% total span). Relative to the alternative average ($58.31), this card is -98%.
Notable alternatives include Cynthia's Garchomp ex #104 (Destined Rivals) at $0.97, Cynthia's Garchomp ex #241 (Destined Rivals) at $32.83, Cynthia's Garchomp ex #215 (Destined Rivals) at $5.34, and Cynthia's Garchomp ex #232 (Destined Rivals) at $194.11.
Market structure summary: Short-term momentum is positive (10.2% over 7 days), while the card sits 10% above its 90-day low. With a 16% 90-day spread ($0.88-$1.04), this card currently tracks as low-volatility.
Relative to the 30-day baseline ($0.95), pricing is near equilibrium. No consistent graded benchmark is available in this snapshot, so condition-adjusted pricing should be reviewed with active listings.
